Laboratorios Farma | ROVI - Trade Creditors

Stock Price
58.95
Daily Change
-0.45 -0.76%
Monthly
-30.73%
Yearly
13.47%
Q2 Forecast
57.41

Laboratorios Farma reported EUR107.59M in Trade Creditors for its fiscal semester ending in December of 2023.





Trade Creditors Change Date
Akebia Therapeutics USD 8.39M 12.8M Mar/2026
Alaunos Therapeutics USD 400K 213K Mar/2026
Almirall EUR 258.05M 58.66M Dec/2025
Avita Medical AUD 8.96M 1.69M Dec/2025
Dianthus Therapeutics USD 5.27M 4.45M Mar/2026
Ionis Pharmaceuticals USD 26.03M 2.05M Mar/2026
IQVIA Holdings USD 3.64B 112M Mar/2026
Laboratorios Farma EUR 107.59M 341K Dec/2023
Moderna USD 161M 156M Mar/2026
Organon & Co USD 983M 31M Mar/2026
Pharma Mar EUR 43.83M 10.51M Mar/2026
Revvity USD 169.68M 15.78M Mar/2026
Tectonic Therapeutic USD 2.55M 1.46M Mar/2026
Viatris USD 1.2B 93.9M Mar/2026
Xeris Pharmaceuticals USD 11.47M 8.39M Mar/2026